enVVeno Medical Corporation (NVNO) Q3 2024 Earnings
NVNO·Reported October 30, 2024·Before market open
Diluted EPS came in at $-0.35, missed the $-0.33 consensus by $0.02.
Diluted EPS
$-0.35missed by $0.02
Consensus: $-0.33
Financial Snapshot
Trailing eight quarters through Q3 2024
Q3 2024 Earnings FAQ
Common questions about enVVeno Medical Corporation's Q3 2024 earnings report.
enVVeno Medical Corporation (NVNO) reported Q3 2024 earnings on October 30, 2024 before market open.
enVVeno Medical Corporation reported diluted EPS of $-0.35 for Q3 2024.
EPS missed the consensus estimate of $-0.33 by $0.02.
You can read the 10-Q periodic report (0001493152-24-043100) directly on SEC EDGAR. The filing index links above go to sec.gov.